8
Participants
Start Date
March 31, 2005
Primary Completion Date
July 31, 2012
Study Completion Date
July 31, 2012
NK-92 cells
"Cells are administered as an intravenous infusion over one hour on days 1, 3 and 5 of each cycle of treatment. Patients can receive up to 6 cycles, which are administered monthly. Cell dosage is as follows:~* Level I: 1x10\^9 cells/m\^2~* Level II: 3x10\^9 cells/m\^2~* Level III: 5x10\^9 cells/m\^2"
Princess Margaret Hospital, Toronto
University Health Network, Toronto
OTHER